cGxP.wire https://validator.w3.org/feed/docs/rss2.html Lirum Therapeutics LX-101 Shows Strong Ewing Data Rznomics RZ-001 Shows Strong HCC Clinical Data AACR Enara Bio Showcases ENA101 Cancer Immunotherapy at AACR Astellas and Pfizer Gain FDA Priority Review for PADCEV Combo Nektar Rezpegaldesleukin Shows 52-Week Alopecia Results Verismo SynKIR-110 Shows Phase 1 Safety in Solid Tumors Nanostics AI ClarityDX Prostate Study Improves Cancer Detection EMA Recommends First RNA-Based Veterinary Vaccine in EU UCB Acquires Neurona to Advance Epilepsy Cell Therapy AstraZeneca Reports Phase III Success for Tozorakimab in COPD CMP Pharma Introduces Alcohol-Free Norliqva for Pediatrics QuidelOrtho Acquires LEX to Boost Rapid PCR Diagnostics Texas Biomed Advances AI Tools to Transform Drug Testing Boehringer Ingelheim Expands AI Innovation Hub in UK Eli Lilly to Acquire Kelonia for In Vivo CAR-T Breakthrough Novo Nordisk Reports Etavopivat Phase 3 Breakthrough Revolution Medicines Reports Breakthrough Zoldonrasib Data Synthetic Design Lab Unveils Logic-Gated ADC Platform Monopar Reports Phase 3 ALXN1840 Data at AAN 2026 EpiBiologics Doses First Patient in EPI-326 Phase 1 Study Nanobiotix Reports Nanoprimer Breakthrough at AACR 2026 Philips Verida AI Spectral CT Wins FDA 510(k) Clearance LEO Pharma Wins China Approval for Enstilar Psoriasis Drug Abbott Cancerguard Advances Multi-Cancer Detection Data Piramal, Ajinomoto Partner to Boost ADC Manufacturing Intelligent Bio Advances FDA 510(k) with Cybersecurity Lilly Foundayo Shows Strong Phase 3 Diabetes Results Gilead Secures Approvals for Arcellx Acquisition Deal Corify Care Gains FDA Clearance for ACORYS 4D Mapping Xodus Medical Gains FDA Clearance for Hot Pink Pad Kura Oncology Shows Strong RCC Data with Combo Therapy Marengo Reports Phase 2 Breast Cancer Data at AACR Merck ENFLONSIA Approved in EU for Infant RSV Protection Nuvalent Zidesamtinib Shows Strong NSCLC Trial Results Radiopharm Theranostics Advances RAD101 Brain Imaging Trial City of Hope Unveils AI and Cancer Breakthroughs at AACR Aligos-Amoytop $445M HBV Licensing Deal Expands Access Janux Therapeutics Doses First Patient in JANX014 Study Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug Mapi Pharma GA Depot Shows Strong MS Progression Control AIM ImmunoTech Advances Ampligen Phase 3 Cancer Trial Khondrion Doses First Patient in Phase 3 KHENERFIN Study MAIA Activates U.S. Site for Phase 2 Lung Cancer Trial PharmaTher Peptide Policy Boosts Microneedle Strategy Neurelis Shows Strong Seizure Control Data for VALTOCO at AAN Boehringer Ingelheim Zongertinib Shows Strong NSCLC Results Fate Therapeutics FT839 CAR T Shows Strong Preclinical Data Foundation Medicine Expands MRD Platform with SAGA Deal AIRS Medical SwiftMR Gains FDA Clearance for MRI AI Interna, Daiichi Sankyo Partner on Drug Delivery Tech